Eli Lilly and Co (LLY)
745.69
+14.36
(+1.96%)
USD |
NYSE |
Apr 23, 16:00
747.00
+1.31
(+0.18%)
Pre-Market: 08:07
Eli Lilly Total Long Term Debt (Quarterly): 25.23B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 25.23B |
September 30, 2023 | 20.17B |
June 30, 2023 | 18.82B |
March 31, 2023 | 18.88B |
December 31, 2022 | 16.24B |
September 30, 2022 | 15.89B |
June 30, 2022 | 16.81B |
March 31, 2022 | 16.51B |
December 31, 2021 | 16.88B |
September 30, 2021 | 17.09B |
June 30, 2021 | 16.52B |
March 31, 2021 | 16.20B |
December 31, 2020 | 16.60B |
September 30, 2020 | 16.92B |
June 30, 2020 | 16.33B |
March 31, 2020 | 17.23B |
December 31, 2019 | 15.32B |
September 30, 2019 | 15.23B |
June 30, 2019 | 15.79B |
March 31, 2019 | 15.97B |
December 31, 2018 | 10.30B |
September 30, 2018 | 12.68B |
June 30, 2018 | 12.22B |
March 31, 2018 | 11.70B |
December 31, 2017 | 13.65B |
Date | Value |
---|---|
September 30, 2017 | 13.46B |
June 30, 2017 | 12.31B |
March 31, 2017 | 10.25B |
December 31, 2016 | 10.31B |
September 30, 2016 | 9.349B |
June 30, 2016 | 9.331B |
March 31, 2016 | 8.126B |
December 31, 2015 | 7.978B |
September 30, 2015 | 8.079B |
June 30, 2015 | 7.999B |
March 31, 2015 | 8.221B |
December 31, 2014 | 8.022B |
September 30, 2014 | 5.606B |
June 30, 2014 | 5.311B |
March 31, 2014 | 5.264B |
December 31, 2013 | 5.213B |
September 30, 2013 | 5.283B |
June 30, 2013 | 5.314B |
March 31, 2013 | 5.460B |
December 31, 2012 | 5.531B |
September 30, 2012 | 5.52B |
June 30, 2012 | 5.509B |
March 31, 2012 | 5.414B |
December 31, 2011 | 6.987B |
September 30, 2011 | 7.08B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
15.23B
Minimum
Sep 2019
25.23B
Maximum
Dec 2023
17.30B
Average
16.60B
Median
Dec 2020
Total Long Term Debt (Quarterly) Benchmarks
Amgen Inc | 64.61B |
Biogen Inc | 6.938B |
Madrigal Pharmaceuticals Inc | -- |
Vertex Pharmaceuticals Inc | 0.00 |
Viking Therapeutics Inc | -- |